VEST

背心
  • 文章类型: Journal Article
    在冠状动脉旁路移植术(CABG)期间,隐静脉移植物(SVGs)的外支架已被证明可以减少动物模型中的内膜增生(IH)。为进行人体随机对照试验(RCTs)铺平了道路。在这里,我们进行了一项研究水平的荟萃分析,以评估静脉外支持(VEST)装置的影响,一个外部支架,关于SVG的结果。进行了系统搜索,以鉴定所有RCT,比较接受CABG的患者中VEST支架与非支架SVG。主要结果是移植物闭塞。主要次要结果是重复血运重建,SVGIH区域,和内膜-内侧厚度。包括两个RCT,总计407名患者。平均随访1.5年,两组间移植物闭塞无差异(发生率比:1.11;95%置信区间(CI):0.80~1.53).重复血运重建率也相似(比值比:0.66;95%CI:0.27-1.64)。VEST组的IH面积(标准化平均差(SMD):-0.45;95%CI:-0.79至-0.10)和内膜-中层厚度(SMD:-0.50;95%CI:-0.90至-0.10)显着减少。我们的发现表明,与CABG后1.5年的非支架SVG相比,VEST支架SVG的IH面积和内膜-中层厚度的显着减少目前并未转化为对重复血运重建的需求减少或移植物闭塞事件减少。
    The external stenting of saphenous vein grafts (SVGs) during coronary artery bypass grafting (CABG) has been proven to reduce intimal hyperplasia (IH) in animal models, paving the way for human randomized controlled trials (RCTs) to be conducted. Herein, we performed a study-level meta-analysis to assess the impact of the Venous External SupporT (VEST) device, an external stent, on the outcomes of SVGs. A systematic search was conducted to identify all RCTs comparing VEST-stented to non-stented SVGs in patients undergoing CABG. The primary outcome was graft occlusion. The main secondary outcomes were repeat revascularization, SVG IH area, and intimal-medial thickness. Two RCTs totaling 407 patients were included. At a mean follow-up of 1.5 years, there was no difference in graft occlusion between groups (incidence rate ratio: 1.11; 95% confidence interval (CI): 0.80-1.53). The rate of repeat revascularization was also similar (odds ratio: 0.66; 95% CI: 0.27-1.64). The IH area (standardized mean difference (SMD): -0.45; 95% CI: -0.79 to -0.10) and intimal-medial thickness (SMD: -0.50; 95% CI: -0.90 to -0.10) were significantly reduced in the VEST group. Our findings show that significant reductions in the IH area and the intimal-medial thickness in VEST-stented SVGs do not currently translate into a lesser need for repeat revascularization or less graft occlusion events compared to non-stented SVGs at 1.5 years after CABG.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    大隐静脉移植物(SVG)是冠状动脉旁路移植术(CABG)中最常用的导管,但与动脉导管相比,它们的闭塞率更高仍然是一个问题。以前的研究表明,SVG衰竭主要是由内膜增生引起的,对动脉循环高压的适应性反应。VESTTM设备(血管移植解决方案,特拉维夫,以色列),旨在减轻SVG内膜增生的外部支架,已经在少数临床试验(RCTs)中进行了测试。在这里,我们描述性地评估了VEST装置上的随机证据.
    Saphenous vein grafts (SVGs) are the most frequently used conduits in coronary artery bypass grafting (CABG), but their higher rate of occlusion compared to arterial conduits remains a concern. Previous studies have shown that SVG failure is mainly driven by intimal hyperplasia, an adaptative response to higher pressures of the arterial circulation. The VESTTM device (Vascular Graft Solutions, Tel Aviv, Israel), an external support designed to mitigate intimal hyperplasia in SVGs, has been tested in few clinical trials (RCTs). Herein, we descriptively evaluated the randomized evidence on the VEST device.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:有强有力的证据表明运动对多发性硬化症(MS)患者的益处,然而,高达80%的MS患者报告说,随着体温升高,症状加剧。已经研究了一系列帮助MS患者管理热敏感性症状的降温服装。因此,这项系统评价的目的是评估降温服装改善MS患者身体功能的效果,并确定任何相关的生理和知觉反应。
    方法:进行了符合PRISMA指南的系统评价。资格标准要求调查必须进行随机对照试验或交叉研究,以评估降温服装改善身体功能的效果。或相关的生理或感知测量,在与女士的人
    结果:确定了13项实证研究,急性交叉设计的妥协(61.5%),纵向平行组设计(23.1%)或两者的组合(15.4%)。研究包括384名MS参与者,其残疾状况量表范围为1-7.5。服装包括液体灌注的冷却背心/上衣/头巾(50.0%),相变冷却背心(38.9%),冷却大腿袖口(5.6%)和手掌冷却装置(5.6%)。冷却服装有效地提高了步行能力和功能流动性,一些研究证明了肌肉力量和平衡的改善,但不是手动灵巧。这些服装还提高了核心温度,皮肤温度,热感觉和主观疲劳。在温带和温暖的条件下发生了改善,有和没有运动刺激。
    结论:降温服装可以改善MS患者的身体机能。由于没有一件冷却服装造成伤害,没有特别的冷却服装可以被认为是优越的,患有MS的人应该尝试不同的冷却服装,以确定他们的偏好,行业应该专注于冷却有效的服装,可访问和用户友好。
    BACKGROUND: There is strong evidence for the benefits of exercise for people with Multiple Sclerosis (MS), however, up to 80% of people with MS report experiencing exacerbated symptoms with elevated body temperatures. A range of cooling garments to assist people with MS manage symptoms of heat sensitivity have been investigated. Therefore, the aim of this systematic review was to assess the effect of cooling garments to improve physical function in people with MS, and to determine any associated physiological and perceptual responses.
    METHODS: A systematic review adhering to the PRISMA guidelines was performed. The eligibility criteria required investigations to have conducted a randomized controlled trial or cross-over study to assess the effect of a cooling garment to improve physical function, or a related physiological or perceptual measure, in people with MS.
    RESULTS: Thirteen empirical studies were identified, compromising of acute cross-over designs (61.5%), longitudinal parallel group designs (23.1%) or a combination of both (15.4%). The studies included 384 participants with MS with an expanded disability status scale range of 1-7.5. Garments included liquid-perfused cooling vests/tops/hoods (50.0%), phase-change cooling vests (38.9%), a cooling thigh-cuff (5.6%) and a palm cooling device (5.6%). The cooling garments were effective at improving walking capacity and functional mobility, and some studies demonstrated improvements in muscular strength and balance, but not manual dexterity. The garments also resulted in improved core temperature, skin temperature, thermal sensation and subjective fatigue. Improvements occurred in temperate and warm conditions, and both with and without an exercise stimulus.
    CONCLUSIONS: Cooling garments can improve physical function for people with MS. Since none of the cooling garments caused harm, and no particular cooling garment could be identified as being superior, people with MS should experiment with different cooling garments to determine their preference, and industry should focus on cooling garments that are effective, accessible and user-friendly.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号